• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

ACMG Foundation receives funding from Pfizer for genetics training residencies/fellowships

Bioengineer by Bioengineer
January 24, 2018
in Biology, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The ACMG Foundation for Genetic and Genomic Medicine announced that it has received a $165,000 commitment from Pfizer to provide funding for education and training in clinical genetics in the form of fellowship grants for 2017-2019.

The ACMG Foundation/Pfizer Clinical Genetics Training Fellowship Award will provide funding for the salary and research of fellows selected by the ACMG Foundation.

Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation said, "We are grateful to Pfizer for their continuing commitment to supporting the training of the next generation of medical geneticists. This is an investment that will help ensure that the rapid advances in genetics and genomics are quickly translated into the better care of our patients."

"Pfizer has generously supported the training of future geneticists since 2013 through the ACMG Foundation," says ACMG Foundation Executive Director, Michael S. Watson, PhD, FACMG. "Together, with Pfizer's support we are working to overcome the shortage of laboratory and clinical geneticists in the United States. These fellowships will ultimately improve access to specialists with advanced training in genetics and genomics, improve care for patients with both rare and common diseases, and develop clinician scientists."

Michael P. Wajnrajch, MD, MPA, Pfizer's Senior Medical Director/Global Medical Affairs Lead said, "Pfizer is proud to partner with ACMG to promote greater education and awareness in the field of Medical Genetics."

More information about applying for the ACMG Foundation/Pfizer Clinical Genetics Training Fellowship Award will be available during the summer of 2016 at http://www.acmgfoundation.org.

###

About the ACMG Foundation

The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics in healthcare. Established in 1992, the ACMG Foundation for Genetic and Genomic Medicine supports the American College of Medical Genetics and Genomics; mission to "translate genes into health" by raising funds to attract the next generation of medical geneticists and genetic counselors, to sponsor important research, to promote information about medical genetics, and much more.

To learn more about the important mission and projects of the ACMG Foundation for Genetic and Genomic Medicine and how you too can support this great cause, please visit http://www.acmgfoundation.org or contact us at [email protected] or 301-718-2014.

Media Contact

Kathy Ridgely Beal
[email protected]
@theacmg

http://www.acmg.net

Share12Tweet8Share2ShareShareShare2

Related Posts

Dorsoventral Hippocampus Reactivates After Aversive Sleep

April 1, 2026

ALDH1L2 Controls ROS and Pancreatic Cell Changes

April 1, 2026

Tim-3 Agonist Limits ILC2, Eases Airway Reactivity

April 1, 2026

Correcting Clock and Bmal1’s Role in Cancer Cells

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dorsoventral Hippocampus Reactivates After Aversive Sleep

ALDH1L2 Controls ROS and Pancreatic Cell Changes

Tim-3 Agonist Limits ILC2, Eases Airway Reactivity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.